Up nextNext guide
California AI Transparency Act (SB 942, amended by AB 853)
Society
Society GUIDE
California SB 1120, the Physicians Make Decisions Act, took effect January 1, 2025 and regulates specified health-plan utilization review and management that uses AI, algorithms or software.
It does not ban clinical decision-support tools, but a tool cannot itself deny, delay or modify care based on medical necessity in place of a qualified clinician’s review.
California enacted SB 1120 as Chapter 879 of the Statutes of 2024, effective January 1, 2025. Often called the Physicians Make Decisions Act, it amended Health and Safety Code §1367.01 and Insurance Code §10123.135. The law applies to health care service plans, health insurers and relevant contracted entities that use artificial intelligence, algorithms or other software tools in utilization review or utilization management based in whole or in part on medical necessity. Utilization review can be prospective, concurrent or retrospective.
Covered entities must ensure these tools comply with applicable standards and are not used to supplant the role of a licensed physician or other qualified health professional. The tool may not deny, delay or modify health care services based on medical necessity. A qualified, appropriately licensed professional with competence in the relevant field must make that decision after reviewing the requesting provider’s recommendation, the patient’s medical history and individual clinical circumstances. The law also requires consideration of relevant patient-specific clinical information, nondiscrimination, fair and equitable application, auditability, written policies describing use and oversight, periodic performance review, and limits on use of patient data beyond the stated purpose.
SB 1120 is not a categorical ban on algorithms, automation or decision support. It governs a payer-side review process and preserves human clinical decision-making for medical-necessity determinations. A health plan should distinguish administrative automation from a covered medical-necessity decision and account for contracted entities. Certain Medi-Cal managed-care application is conditioned on federal approvals and financing, so the scope should not be simplified into a single universal rule for every program.
Catastrophic and everyday AI harms both depend on who understands the risks and who can act.
Public and professional literacy shapes whether strong safety policy is politically possible.
Clear explanations reduce capture by hype, lab PR, and vague ethics theater.
The statute is in force, while implementation may involve department guidance and program-specific conditions. Plans should revisit controls when guidance, contracts, software functions or the covered clinical workflow changes, and confirm the current code text before making a compliance determination. Maintain a dated record of the official source checked, the relevant section and any operational interpretation. When facts change, update policies and training materials together so staff do not rely on a stale summary or treat a proposed measure as an effective legal requirement.
A health plan reviews its automated prior-authorization workflow to ensure a qualified physician or clinician makes the medical-necessity decision.
A reviewer considers the patient’s history and individual clinical circumstances instead of relying only on group-level data.
A plan documents the tool’s purpose, oversight, periodic performance review and audit practices in written policies.
A vendor contract identifies how the tool supports, rather than replaces, provider and qualified clinician judgment.
Treating existential risk as sci-fi while capability compounds.
Confusing surface product safety with alignment under high autonomy.
Leaving non-English and non-expert audiences with only low-quality sources.
Separate product harms, misuse, and loss-of-control / misalignment risks.
Ask what evidence would change your view on timelines and severity.
Prefer primary sources and concrete evals over marketing claims.
Identify one action path: career, policy, funding, or skills — not only awareness.
Free newsletter
One short email each weekday with the three AI stories that actually matter. Free forever, no ads.
One email each weekday. Unsubscribe in one click. We never sell or share your address.
Test yourself
Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.
Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation
California SB 1120, the Physicians Make Decisions Act, took effect January 1, 2025 and regulates specified health-plan utilization review and management that uses AI, algorithms or software. It does not ban clinical decision-support tools, but a tool cannot itself deny, delay or modify care based on medical necessity in place of a qualified clinician’s review.
SB1120 was approved in 2024 and became effective January 1, 2025.
The law amends plan and insurer utilization-review provisions concerning medical necessity.
The statute requires a qualified clinician to decide after reviewing the specified provider and patient information.
The statute bars the tool from denying, delaying or modifying care on medical-necessity grounds.
The text requires review of the requesting provider’s recommendation, medical history and individual clinical circumstances.
Keep learning
More guides picked for this topic
Up nextNext guide
California AI Transparency Act (SB 942, amended by AB 853)
Society